Erbitus prolongs life expectancy for lung cancer patients: study (AFP)
June 2, 2008
AFP - The cancer drug Erbitux (cetuximab) prolonged the lives of patients with advanced lung cancer by five weeks, according to a clinical study described Sunday as an important gain for such individuals.
Study: Kids' cancer rates highest in Northeast
Surprising research suggests that childhood cancer is most common in the Northeast, results that even caught experts off guard. But some specialists say it could just reflect differences in reporting.
Study: Kids' cancer rates highest in Northeast (AP)
AP - Surprising research suggests that childhood cancer is most common in the Northeast, results that even caught experts off guard. But some specialists say it could just reflect differences in reporting.
Celebrex May Reduce Levels of Lung...
HealthDay - SUNDAY, June 1 (HealthDay News) -- A widely prescribed pain
reliever may one day have value in helping to prevent lung cancer.
06/02/08
Similar news about Biology
New Hope for Tough-to-Treat Cancers ...
HealthDay - SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with
pancreatic cancer -- which historically carries a grim prognosis -- nearly
doubled their overall...
06/01/08
Similar news about Medical
Erbitux slightly boosts survival in...
AP - Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found.
06/01/08
Similar news about Medical
Bone drug helped stave off breast...
Reuters - A drug used to strengthen the bones of
women with breast cancer helped cut the risk of the cancer
returning by 36 percent, European researchers said on Saturday,
06/01/08
Similar news about Medical
Celebrex shows promise in lung cancer...
Reuters - A high dose of the arthritis drug
Celebrex showed early signs that it may help prevent lung
cancer in heavy smokers, U.S. researchers said on Sunday.
06/01/08
Similar news about Medical
Celebrex May Reduce Levels of Lung...
HealthDay - SUNDAY, June 1 (HealthDay News) -- A widely prescribed pain
reliever may one day have value in helping to prevent lung cancer.
06/01/08
Similar news about Biology
U.S. Childhood Cancers Vary by Sex, Region (HealthDay)
HealthDay - MONDAY, June 2 (HealthDay News) -- A sweeping government study of childhood cancers has found numerous differences in cancer types depending on a child's age, sex, race and where he or she lives in the United States.
Bone Drug Lowers Risk of Breast Cancer Recurrence (HealthDay)
HealthDay - SATURDAY, May 31 (HealthDay News) -- A drug used to treat osteoporosis lowered the risk of breast cancer recurrence in premenopausal women with early breast cancer.
Celebrex shows promise in lung cancer...
Reuters - A high dose of the arthritis drug
Celebrex showed early signs that it may help prevent lung
cancer in heavy smokers, U.S. researchers said on Sunday.
06/01/08
Similar news about Medical
U.S. Childhood Cancers Vary by Sex,...
HealthDay - MONDAY, June 2 (HealthDay News) -- A sweeping government study
of childhood cancers has found numerous differences in cancer types
depending on a child's age, sex,...
06/03/08
Similar news about Neurobiology
Bone Drug Lowers Risk of Breast...
HealthDay - SATURDAY, May 31 (HealthDay News) -- A drug used to treat
osteoporosis lowered the risk of breast cancer recurrence in premenopausal
women with early breast cancer.
06/03/08
Similar news about Medical
New Hope for Tough-to-Treat Cancers ...
HealthDay - SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with
pancreatic cancer -- which historically carries a grim prognosis -- nearly
doubled their overall...
06/03/08
Similar news about Medical
Celebrex May Reduce Levels of Lung...
HealthDay - SUNDAY, June 1 (HealthDay News) -- A widely prescribed pain reliever
may one day have value in helping to prevent lung cancer.
06/03/08
Similar news about Biology
Family History Might Improve Odds...
HealthDay - TUESDAY, June 3 (HealthDay News) -- The genetic makeup that
increases the risk of developing colorectal cancer also seems to improve
the chances of survival after...
06/03/08
Similar news about Biology
New Hope for Tough-to-Treat Cancers (HealthDay)
HealthDay - SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with pancreatic cancer -- which historically carries a grim prognosis -- nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows.
New Hope for Tough-to-Treat Cancers (HealthDay)
HealthDay - SATURDAY, May 31 (HealthDay News) -- Patients diagnosed with pancreatic cancer -- which historically carries a grim prognosis -- nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows.
US cancer researchers attack federal...
AFP - Consistent reductions in US federal budget allocations for cancer research that have been implemented since 2003 threaten to undermine recent gains in the fight against...
05/31/08
Similar news about Medical
Bone drug Zometa helps fight breast...
A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new...
05/31/08
Similar news about Medical
Bone drug Zometa helps fight breast...
AP - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible...
05/31/08
Similar news about Medical
Bone drug helped stave off breast...
Reuters - A drug used to strengthen the bones of
women with breast cancer helped cut the risk of the cancer
returning by 36 percent, European researchers said on Saturday,
05/31/08
Similar news about Medical
Bone drug Zometa helps fight breast...
AP - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible...
05/31/08
Similar news about Medical
Bone drug Zometa resists...
A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new...
05/31/08
Similar news about Medical